Elena Rafailovska

Dr. Elena Rafailovska

Institute of Biology, SS Cyril and Methodius, Skoppje, North Macedonia, Skopje, North Macedonia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ERElena Rafailovska
Elena Rafailovska
OTOliver Tusevski
Oliver Tusevski
KSKristiana Shijakova
Kristiana Shijakova
SSSonja Gadzovska Simic
Sonja Gadzovska Simic
SKSuzana Dinevska Kjovkarovska
Suzana Dinevska Kjovkarovska
BMBiljana Miova
Biljana Miova

21 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ERElena Rafailovska
Elena Rafailovska
EXElona Xhemaili
Elona Xhemaili
ZNZorica Naumovska
Zorica Naumovska
OGOlga Gigopulu
Olga Gigopulu
BMBiljana Miova
Biljana Miova
GSGjoshe Stefkov
Gjoshe Stefkov
Background/Objectives: Diabetes mellitus is a growing global health concern, driving the exploration of new therapies like cannabidiol (CBD), which shows potential in improving insulin sensitivity and glycemic control, though its effects on glucose metabolism remain unclear. This study evaluates CBD’s dose-dependent effects on glycemia, insulin, and hepatic carbohydrate metabolism in diabetic rats. Methods: The Oral Glucose Tolerance Test (OGTT) was performed in healthy rats to compare intragastric vs. intraperitoneal CBD (0.5, 5, 50 mg/kg). Diabetic rats were treated with intragastric CBD (25, 50, 100 mg/kg) or metformin (70 mg/kg) for 8 days. Blood glucose, insulin, lipid profiles, and key carbohydrate-metabolizing enzymes were analyzed. Results: In the OGTT, intragastric CBD reduced glycemic AUC, with 50 mg/kg showing the strongest effect, while intraperitoneal CBD had no impact. In diabetic rats, metformin and 25 mg/kg CBD lowered blood glucose, but only CBD increased insulin. The 50 mg/kg dose caused the greatest glucose reduction and moderate insulin rise, while 100 mg/kg had no effect. At 25 mg/kg, CBD inhibited glucose-6-phosphatase and increased glucose-6-phosphate. The 50 mg/kg dose further suppressed gluconeogenic enzymes, reduced glycogen phosphorylase and liver glucose, and enhanced glucose-6-phosphate, showing the strongest metabolic effects. The 100 mg/kg dose increased hexokinase but had weaker metabolic effects. Metformin improved glucose utilization and glycogen storage. CBD at 25 and 50 mg/kg reduced triacylglycerols and increased HDL, while 100 mg/kg had no effect. Conclusions: This study provides strong evidence of CBD’s antidiabetic potential, especially at 50 mg/kg, particularly through its modulation of glucose metabolism and tendency to regulate insulin levels.

1 March 2022 in Macedonian Veterinary Review
Verified
Journal Article
Open access
PDF file
ERElena Rafailovska
Elena Rafailovska
OTOliver Tushevski
Oliver Tushevski
SGSonja Gadzovska-Simic
Sonja Gadzovska-Simic
SDSuzana Dinevska-Kjovkarovska
Suzana Dinevska-Kjovkarovska
BMBiljana Miova
Biljana Miova
Apart from currently available therapeutics for the treatment of diabetes mellitus, much attention has been paid to discover phytochemicals from natural resources, mainly due to their low side-effects. Hypericum perforatum hairy root (HR) transformed with Agrobacterium rhizogenes A4 represent prospective experimental system enriched in xanthones, known as potent antidiabetic agents. Thus, the aim of this study was to evaluate HR extracts for their potential antihyperglycemic activity in streptozotocin (STZ)-induced diabetic rats, also compared to the effects of wild-growing Hyperici herba (HH). We conducted an acute-toxicity study, multiple dose study, and 24h blood glucose measurements after a single dose administration of HH and HR (200 mg/kg) in diabetic rats. Furthermore, we examined the effects of 14-days administration of HH and HR extracts on blood glucose levels, metabolic parameters, enzyme, and lipid status in healthy and diabetic rats. Both extracts produced a fall of about 70% in blood glucose level after 24h of administration. Two-week treatment with HH and HR induced a significant decrease (70-72%) in blood glucose levels. Moreover, we found an improvement of the dysregulated metabolic parameters (body weight, food, and water consumption and urine output). Serum enzyme (AST, ALT, and γ-GT) and lipid profile parameters (CHOL, TAG, and HDL) were also improved by both extracts. These findings might provide a new insight for managing diabetic hyperglycemia and dysregulated serum enzyme and lipid profile, using extracts from transgenic roots cultures from H. perforatum.

18 April 2024 in Macedonian Journal of Chemistry and Chemical Engineering
Verified
Journal Article
Open access
PDF file
ERElena Rafailovska
Elena Rafailovska
OTOliver Tusevski
Oliver Tusevski
SSSonja Gadzovska- Simic
Sonja Gadzovska- Simic
SPSasho Panov
Sasho Panov
JSJasmina Petreska Stanoeva
Jasmina Petreska Stanoeva
BMBiljana Miova
Biljana Miova
Hairy root (HR) cultures of Hypericum perforatum L. have shown promise in controlling hyperglycemia, regulating blood lipid and enzyme profiles, and improving metabolic function in vivo. These benefits are mainly attributed to the phenolic acids, flavonoids, and xanthones present in HR extracts. However, the specific mechanism underlying these effects remains unclear. This study was performed to elucidate the biochemical and molecular mechanisms driving HR the antihyperglycemic and antidiabetic effects of HR extracts. HR extract (200 mg/kg body weight) was administered daily for 14 days to healthy rats and rats with streptozotocin-induced diabetes, with glibenclamide serving as a positive control. The phenolic composition of the HR extracts was confirmed through high-performance liquid chromatography/diode array detection/electrospray ionization mass spectrometry (HPLC/DAD/ESI-MSn ) analysis. The results showed that HR extract treatment increased the plasma insulin level and pancreatic poly (adenosine diphosphate-ribose) polymerase (PARP) activity in diabetic rats, thus normalizing blood glucose levels. Additionally, it reduced the activity of gluconeogenic enzymes, increased the activity of glycolytic enzymes, and normalized the glycogen content in the liver. HR extract-treated rats also exhibited increased hepatic adenosine monophosphate-activated protein kinase (AMPK) mRNA expression and a decreased protein kinase Cε (PKCε) concentration. In conclusion, HR extract demonstrated insulinotropic effects and effectively regulated hepatic carbohydrate metabolism in diabetic rats by modulating AMPK expression and the PKCε concentration. These findings suggest the potential use of HR extract as an herbal medicine for diabetes treatment and a source of antidiabetic drug development.

1 October 2022 in Macedonian Veterinary Review
Verified
Journal Article
Open access
PDF file
MDMirsada Dervisevik
Mirsada Dervisevik
SDSuzana Dinevska-Kjovkarovska
Suzana Dinevska-Kjovkarovska
SPSasho Panov
Sasho Panov
ERElena Rafailovska
Elena Rafailovska
ICIrena Celevska
Irena Celevska
BMBiljana Miova
Biljana Miova
The myocardium of diabetic subjects displays reduced HSP70 protein level and weak myocardial protection. However, the heart possesses an ability to produce heat shock proteins (HSPs) after exposure to sublethal heat stress. Acetylsalicylicacid (ASA) has the property of pharmacological induction of HSPs. We evaluated the common effects of single dose ASA-pretreatment, prior to heat preconditioning (HP), over carbohydrate metabolism-related enzymes and substrates in the heart of diabetic rats. Streptozotocin-diabetes caused significant decrease of HSP70 protein level, stimulation of the gluconeogenic processes and inhibition of glycolytic processes in the heart. HP-diabetic hearts have significantly higher HSP70 protein level, lower glycogen, glucose-6-phosphate content, glycogen phosphorylase and hexokinase activity, and higher glucose levels and PFK activity. ASA-pretreatment of HP-diabetic animals caused additional increase of HSP70, additional decrease of glycogen, glucose-6-phosphate, glycogen phosphorylase and hexokinase, and additional increase of glucose and PFK in the heart. In conclusion, HP is physiological inducer of HSP70 level in heart and tends to reverse carbohydrate - related disturbances in diabetic rats. ASA, given prior to HP, is a potent HSP70 co-inducer and causes additional increase of HSP70 protein level in heart. ASA, given in a combination to HP, have shown more evident protective effects against subsequent intense of stress.

31 December 2022 in Macedonian Pharmaceutical Bulletin
Verified
Journal Article
Closed access
ERElena Rafailovska
Elena Rafailovska
CTCvetanka Trifunovska
Cvetanka Trifunovska
OTOliver Tushevski
Oliver Tushevski
SSSonja Gadzovska- Simic
Sonja Gadzovska- Simic
SKSuzana Dinevska- Kjovkarovska
Suzana Dinevska- Kjovkarovska
BMBiljana Miova
Biljana Miova